166 related articles for article (PubMed ID: 18228198)
21. Suppression of autoimmune disease and of massive lymphadenopathy in MRL/Mp-lpr/lpr mice lacking tyrosine kinase Fyn (p59fyn).
Takahashi T; Yagi T; Kakinuma S; Kurokawa A; Okada T; Takatsu K; Aizawa S; Katagiri T
J Immunol; 1997 Sep; 159(5):2532-41. PubMed ID: 9278347
[TBL] [Abstract][Full Text] [Related]
22. Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies.
Mohan C; Morel L; Yang P; Watanabe H; Croker B; Gilkeson G; Wakeland EK
J Clin Invest; 1999 Jun; 103(12):1685-95. PubMed ID: 10377175
[TBL] [Abstract][Full Text] [Related]
23. Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice.
Entani C; Izumino K; Iida H; Fujita M; Asaka M; Takata M; Sasayama S
Nephron; 1993; 64(3):471-5. PubMed ID: 7688103
[TBL] [Abstract][Full Text] [Related]
24. Fas
Bohat R; Liang X; Chen Y; Xu C; Zheng N; Guerrero A; Hou J; Jaffery R; Egan NA; Li Y; Tang Y; Unsal E; Robles A; Chen S; Major AM; Elldakli H; Chung SH; Liang H; Hicks MJ; Du Y; Lin JS; Chen X; Mohan C; Peng W
Clin Immunol; 2024 Jan; 258():109874. PubMed ID: 38113962
[TBL] [Abstract][Full Text] [Related]
25. Genetic selection for crescent formation yields mouse strain with rapidly progressive glomerulonephritis and small vessel vasculitis.
Kinjoh K; Kyogoku M; Good RA
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3413-7. PubMed ID: 8475090
[TBL] [Abstract][Full Text] [Related]
26. Long-term treatment with 5,5-diphenylhydantoin reduces lymphadenopathy and anti-ssDNA autoantibodies in C57BL/6-lpr/lpr mice.
Bloksma N; de Bakker JM; van Rooijen HJ; Punt P; Seinen W; Kammüller ME
Int J Immunopharmacol; 1994 Mar; 16(3):261-8. PubMed ID: 8206693
[TBL] [Abstract][Full Text] [Related]
27. Expression of platelet-derived growth factor in lupus nephritis in MRL/MpJ-1pr/1pr mice.
Entani C; Izumino K; Takata M; Futamura A; Nakagawa Y; Inoue H; Iida H
Nephron; 1997; 77(1):100-4. PubMed ID: 9380223
[TBL] [Abstract][Full Text] [Related]
28. Morphological analysis of autoimmune disease in MRL-lpr,Yaa male mice with rapidly progressive systemic lupus erythematosus.
Suzuka H; Yoshifusa H; Nakamura Y; Miyawaki S; Shibata Y
Autoimmunity; 1993; 14(4):275-82. PubMed ID: 8347770
[TBL] [Abstract][Full Text] [Related]
29. Vasculitis-susceptible genes in mice with a deficit in Fas-mediated apoptosis.
Nose M; Terada M; Nishihara M; Kamogawa J; Miyazaki T; Mori S; Nishimura M; Wang Y; Kamoto T; Hiai H
Int J Cardiol; 1998 Oct; 66 Suppl 1():S37-41; discussion S43. PubMed ID: 9951801
[TBL] [Abstract][Full Text] [Related]
30. Induction of murine autoimmune disease by chronic polyclonal B cell activation.
Hang L; Slack JH; Amundson C; Izui S; Theofilopoulos AN; Dixon FJ
J Exp Med; 1983 Mar; 157(3):874-83. PubMed ID: 6339669
[TBL] [Abstract][Full Text] [Related]
31. Effects of cyclosporin A on autoimmune disease in MRL/1 and BXSB mice.
Berden JH; Faaber P; Assmann KJ; Rijke TP
Scand J Immunol; 1986 Oct; 24(4):405-11. PubMed ID: 3489984
[TBL] [Abstract][Full Text] [Related]
32. Interaction of mutant lpr gene with background strain influences renal disease.
Kelley VE; Roths JB
Clin Immunol Immunopathol; 1985 Nov; 37(2):220-9. PubMed ID: 4042431
[TBL] [Abstract][Full Text] [Related]
33. Age-associated increase in interleukin 6 in MRL/lpr mice.
Tang B; Matsuda T; Akira S; Nagata N; Ikehara S; Hirano T; Kishimoto T
Int Immunol; 1991 Mar; 3(3):273-8. PubMed ID: 2049341
[TBL] [Abstract][Full Text] [Related]
34. Distinctive expression of lprcg in the heterozygous state on different genetic backgrounds.
Ogata Y; Kimura M; Shimada K; Wakabayashi T; Onoda H; Katagiri T; Matsuzawa A
Cell Immunol; 1993 Apr; 148(1):91-102. PubMed ID: 8495493
[TBL] [Abstract][Full Text] [Related]
35. Presence of anti-Sm reactivity in autoimmune mouse strains.
Eisenberg RA; Tan EM; Dixon FJ
J Exp Med; 1978 Feb; 147(2):582-7. PubMed ID: 304883
[TBL] [Abstract][Full Text] [Related]
36. Effect of methotrexate treatment on the onset of autoimmune kidney disease in lupus mice.
Mihara M; Katsume A; Takeda Y
Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2177-81. PubMed ID: 1423777
[TBL] [Abstract][Full Text] [Related]
37. Induction of "wire-loop" lesions by murine monoclonal IgG3 cryoglobulins.
Lemoine R; Berney T; Shibata T; Fulpius T; Gyotoku Y; Shimada H; Sawada S; Izui S
Kidney Int; 1992 Jan; 41(1):65-72. PubMed ID: 1593863
[TBL] [Abstract][Full Text] [Related]
38. Hearing in the MRL/lpr mouse as a possible model of immune-mediated sensorineural hearing loss.
Inoue Y; Kanzaki J; Ogawa K; Hashiguchi K; Masuda M
Eur Arch Otorhinolaryngol; 1998; 255(5):240-3. PubMed ID: 9638465
[TBL] [Abstract][Full Text] [Related]
39. Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2.
Gilkeson GS; Mudgett JS; Seldin MF; Ruiz P; Alexander AA; Misukonis MA; Pisetsky DS; Weinberg JB
J Exp Med; 1997 Aug; 186(3):365-73. PubMed ID: 9236188
[TBL] [Abstract][Full Text] [Related]
40. Systemic autoimmune nephritogenic components induce CSF-1 and TNF-alpha in MRL kidneys.
Wada T; Naito T; Griffiths RC; Coffman TM; Kelley VR
Kidney Int; 1997 Oct; 52(4):934-41. PubMed ID: 9328932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
